Omnicell Inc (OMCL) 38.22 $OMCL Shares of OMCL Up 32.8%

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 1:16 PM

Omnicell Inc (OMCL) 38.22 $OMCL

Shares of OMCL Up 32.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Aug 31, 12:38AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on April 18th, 2016 at $28.34. In approximately 4 months, Omnicell has returned 32.82% as of today's recent price of $37.64.
OMCL: 38.22 (+0.64)

Omnicell, Inc. (Nasdaq: OMCL) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Mon Aug 29, 9:02AM CDT
What:
OMCL: 38.22 (+0.64), NDAQ: 71.33 (+0.12)

32.1% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Tue Aug 16, 12:39AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on April 18th, 2016 at $28.34. In approximately 4 months, Omnicell has returned 32.07% as of today's recent price of $37.43.
OMCL: 38.22 (+0.64)

Omnicell (OMCL) Tops Q2 Earnings & Revenues, Margins Drag
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:36PM CDT
Omnicell, Inc. (OMCL) reported second-quarter 2016 adjusted earnings per share (EPS) of 29 cents reflecting year-over-year improvement of 61.1%.
LMAT: 18.04 (-0.34), QDEL: 21.78 (+0.01), OMCL: 38.22 (+0.64), NUVA: 65.65 (+0.18)

Omnicell Has Returned 38.4% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Jul 29, 1:24PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on April 18th, 2016 at $28.34. In approximately 3 months, Omnicell has returned 38.36% as of today's recent price of $39.21.
OMCL: 38.22 (+0.64)

Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety at Rochester Regional Health
PR Newswire - Thu Jul 28, 3:11PM CDT
Omnicell, Inc. (NASDAQ: OMCL) today announced that Rochester Regional Health ("Rochester Regional"

, a five-hospital health system in western New York, has selected the Company's medication automation solutions for its hospital floors and operating rooms to promote the highest level of patient care. Formed in 2014, Rochester Regional is currently installing Omnicell® automated medication dispensing systems in two of its five hospitals that collectively serve over 1,300 beds, with plans to implement the automation into all five facilities by 2018.
OMCL: 38.22 (+0.64)

Omnicell Achieves Record Revenue in the Second Quarter 2016
PR Newswire - Thu Jul 28, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its second quarter ended June 30, 2016.
OMCL: 38.22 (+0.64)

Omnicell Grows amid Weak Margins, Hospital Spending Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:57AM CDT
On Jun 1, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDSO: 53.36 (-0.74), DRAD: 5.09 (+0.03), OMCL: 38.22 (+0.64), ATHN: 123.28 (+0.85)

Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Drag
Zacks Equity Research - Zacks Investment Research - Mon May 02, 10:05AM CDT
Omnicell, Inc. (OMCL) reported first-quarter 2016 adjusted earnings per share (EPS) of 30 cents, reflecting year-over-year improvement of 57.9%.
MDSO: 53.36 (-0.74), QSII: 11.74 (-0.03), CPSI: 25.39 (-0.43), OMCL: 38.22 (+0.64)

Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Fri Apr 29, 7:07AM CDT
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced they will present at the Deutsche Bank 41st annual Health Care Conference at the InterContinental Boston Hotel, Boston, MA.
DB: 14.66 (-0.09), OMCL: 38.22 (+0.64)

Omnicell reports 1Q loss
Automated Insights - Thu Apr 28, 4:47PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported a first-quarter loss of $378,000, after reporting a profit in the same period a year earlier.
OMCL: 38.22 (+0.64)

UnityPoint Health® Selects Omnicell Medication Automation, Central Pharmacy and Analytics Solutions to Enhance Patient Safety and Efficiency
PR Newswire - Wed Apr 27, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) today announced that UnityPoint Health® has awarded the Company a 10-year sole source contract as its provider of medication automation, central pharmacy automation and analytics software across 15 of its facilities. UnityPoint Health expects Omnicell's solutions to advance the highest standards of patient safety and security while optimizing pharmacist, nurse and anesthesiologist workflows. Two benefits offered by Omnicell are the Omnicell Unity enterprise platform, which gives health systems enhanced visibility across multiple Omnicell systems, and interoperability with the Epic electronic health record (EHR) system, which is used by UnityPoint Health. Installation is expected to be completed by the end of the year.
OMCL: 38.22 (+0.64)

Omnicell to Release First Quarter 2016 Earnings Results on April 28th
PR Newswire - Thu Apr 21, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, April 28, 2016, to discuss the Company's First Quarter 2016 financial results.
OMCL: 38.22 (+0.64)

UW Health Adds New IV Automation Capabilities and Solutions to Enhance Hybrid Drug Distribution Process
PR Newswire - Wed Apr 06, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) is pleased to report that UW Health, the system associated with the University of Wisconsin-Madison, is adding the i.v.STATION ONCO(TM), which provides robotic sterile compounding of oncology admixtures, to their pharmacy automation solutions. UW Health selected the Aesynt product, now part of Omnicell's product portfolio, for use in the drug distribution process at their main University Hospital as well as in three additional facilities in their health system. In addition, the hospital is updating their existing ROBOT-Rx® automated medication dispensing robot and upgrading their AcuDose-Rx® automated dispensing cabinets. These and other products from Aesynt have recently been added to the Omnicell portfolio, expanding Omnicell's ability to support all key pharmacy distribution models, described as follows:
OMCL: 38.22 (+0.64)

Omnicell Announces New Guided Packing Software Designed to Increase Packing Accuracy of SureMed Multimed Blister Cards which Improve Patient Adherence
PR Newswire - Thu Mar 31, 10:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools to health care systems and pharmacies, today announced general availability of its latest medication adherence solution, the SureMed(TM) by Omnicell® Guided Packing software. This cloud-based software is designed to increase pharmacists' accuracy in filling SureMed multiple medication blister cards, which can improve medication adherence for patients on complex medication regimens. At launch, the software will interface with QS1, one of the most widely used pharmacy information systems (PIS), and is planned to integrate with additional systems later this year.
OMCL: 38.22 (+0.64)

Add Omnicell (OMCL) to Your Investment Portfolio: Here's Why
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:00PM CDT
On Mar 29, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 12.91 (unch), NVTA: 7.90 (+0.05), OMCL: 38.22 (+0.64), ATHN: 123.28 (+0.85)

Omnicell Q4 Earnings, Revenues Rise Y/Y; Aesynt Buyout Over
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 11:30AM CST
Omnicell's (OMCL) outperformance on the revenue front is encouraging. However, the company's performance on the bottom-line front remains mixed.
LMAT: 18.04 (-0.34), VASC: 48.54 (+0.37), OMCL: 38.22 (+0.64), HRC: 59.19 (-0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cut Winter Heating Costs with Townsend's Rebate Help

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Endurance Energy's Modular Tech Revs Up Southeast Asia

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

AST SpaceMobile Faces Class Action Over Misstatements

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Timur Turlov Leads FIDE with Chess and Digital Focus

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

HONA Faces Legal Heat: Investor Lawsuit Over Losses

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Quay Sunglasses: Luxury Looks, Affordable Prices

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

China Southern Airlines Marks 70th Anniversary in NYC

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...